Persistent recruitment delays, high dropout rates, and missed timelines continue to slow global clinical trials, while data show that sub-Saharan Africa offers a largely untapped opportunity with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback